Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 27% ± 10% | |
astrocyte | 8 studies | 25% ± 9% | |
glutamatergic neuron | 6 studies | 37% ± 22% | |
epithelial cell | 6 studies | 32% ± 13% | |
oligodendrocyte | 6 studies | 25% ± 8% | |
macrophage | 5 studies | 21% ± 4% | |
GABAergic neuron | 5 studies | 33% ± 16% | |
natural killer cell | 5 studies | 16% ± 1% | |
neuron | 4 studies | 27% ± 8% | |
microglial cell | 4 studies | 21% ± 4% | |
type I pneumocyte | 4 studies | 18% ± 3% | |
goblet cell | 4 studies | 24% ± 10% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 2% | |
non-classical monocyte | 3 studies | 21% ± 3% | |
myeloid cell | 3 studies | 18% ± 2% | |
ciliated cell | 3 studies | 29% ± 4% | |
fibroblast | 3 studies | 22% ± 3% | |
type II pneumocyte | 3 studies | 19% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 4% | |
abnormal cell | 3 studies | 29% ± 10% | |
basal cell | 3 studies | 30% ± 12% | |
transit amplifying cell | 3 studies | 29% ± 17% | |
interneuron | 3 studies | 34% ± 18% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4721.69 | 1445 / 1445 | 100% | 24.98 | 183 / 183 |
liver | 100% | 3498.69 | 226 / 226 | 100% | 19.90 | 406 / 406 |
ovary | 100% | 4912.47 | 180 / 180 | 100% | 31.49 | 430 / 430 |
pancreas | 100% | 2676.68 | 328 / 328 | 100% | 29.90 | 178 / 178 |
prostate | 100% | 7359.69 | 245 / 245 | 100% | 36.11 | 502 / 502 |
stomach | 100% | 3618.02 | 359 / 359 | 100% | 26.39 | 286 / 286 |
uterus | 100% | 5496.68 | 170 / 170 | 100% | 33.40 | 459 / 459 |
skin | 100% | 3963.00 | 1808 / 1809 | 100% | 38.16 | 472 / 472 |
lung | 100% | 4712.21 | 578 / 578 | 100% | 26.85 | 1154 / 1155 |
thymus | 100% | 6068.99 | 653 / 653 | 100% | 30.23 | 604 / 605 |
brain | 100% | 4674.01 | 2633 / 2642 | 100% | 41.90 | 705 / 705 |
intestine | 100% | 5314.88 | 966 / 966 | 100% | 29.87 | 525 / 527 |
adrenal gland | 100% | 4561.33 | 258 / 258 | 100% | 29.08 | 229 / 230 |
kidney | 100% | 5729.43 | 89 / 89 | 100% | 23.03 | 897 / 901 |
breast | 100% | 4004.50 | 459 / 459 | 100% | 26.58 | 1113 / 1118 |
bladder | 100% | 4693.33 | 21 / 21 | 99% | 29.48 | 501 / 504 |
adipose | 100% | 3427.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 31.15 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.42 | 29 / 29 |
spleen | 100% | 6214.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.04 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 36.74 | 1 / 1 |
blood vessel | 100% | 3627.60 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2610.66 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2803.73 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3005.60 | 909 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051697 | Biological process | protein delipidation |
GO_0000045 | Biological process | autophagosome assembly |
GO_0034497 | Biological process | protein localization to phagophore assembly site |
GO_0034727 | Biological process | piecemeal microautophagy of the nucleus |
GO_0031173 | Biological process | otolith mineralization completed early in development |
GO_0016236 | Biological process | macroautophagy |
GO_0016485 | Biological process | protein processing |
GO_0035973 | Biological process | aggrephagy |
GO_0006501 | Biological process | C-terminal protein lipidation |
GO_0006508 | Biological process | proteolysis |
GO_0016237 | Biological process | microautophagy |
GO_0015031 | Biological process | protein transport |
GO_0000423 | Biological process | mitophagy |
GO_0006914 | Biological process | autophagy |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005739 | Cellular component | mitochondrion |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0019786 | Molecular function | protein-phosphatidylethanolamide deconjugating activity |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0008234 | Molecular function | cysteine-type peptidase activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ATG4B |
Protein name | Cysteine protease (EC 3.4.22.-) Cysteine protease ATG4B (Autophagy-related protein 4 homolog B) Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 1) (Autophagin-1) (Autophagy-related protein 4 homolog B) (HsAPG4B) (hAPG4B) |
Synonyms | AUTL1 APG4B KIAA0943 |
Description | FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins . Required for canonical autophagy (macroautophagy), non-canonical autophagy as well as for mitophagy . The protease activity is required for proteolytic activation of ATG8 family proteins: cleaves the C-terminal amino acid of ATG8 proteins MAP1LC3A, MAP1LC3B, MAP1LC3C, GABARAPL1, GABARAPL2 and GABARAP, to reveal a C-terminal glycine . Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy . Protease activity is also required to counteract formation of high-molecular weight conjugates of ATG8 proteins (ATG8ylation): acts as a deubiquitinating-like enzyme that removes ATG8 conjugated to other proteins, such as ATG3 . In addition to the protease activity, also mediates delipidation of ATG8 family proteins . Catalyzes delipidation of PE-conjugated forms of ATG8 proteins during macroautophagy . Also involved in non-canonical autophagy, a parallel pathway involving conjugation of ATG8 proteins to single membranes at endolysosomal compartments, by catalyzing delipidation of ATG8 proteins conjugated to phosphatidylserine (PS) . Compared to other members of the family (ATG4A, ATG4C or ATG4C), constitutes the major protein for proteolytic activation of ATG8 proteins, while it displays weaker delipidation activity than other ATG4 paralogs . Involved in phagophore growth during mitophagy independently of its protease activity and of ATG8 proteins: acts by regulating ATG9A trafficking to mitochondria and promoting phagophore-endoplasmic reticulum contacts during the lipid transfer phase of mitophagy . . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . |
Accessions | C9J1C1 ENST00000400771.7 ENST00000344376.9 ENST00000404914.8 [Q9Y4P1-1] Q9Y4P1 F2Z2K8 C9JIK8 ENST00000402096.5 [Q9Y4P1-4] ENST00000419606.5 ENST00000400772.6 ENST00000405546.7 [Q9Y4P1-6] ENST00000625810.2 H0Y2Y0 ENST00000415107.5 |